Immunovant
IMVT
IMVT
181 hedge funds and large institutions have $2.57B invested in Immunovant in 2023 Q3 according to their latest regulatory filings, with 61 funds opening new positions, 64 increasing their positions, 44 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% more funds holding
Funds holding: 147 → 181 (+34)
8.66% more ownership
Funds ownership: 42.53% → 51.19% (+8.7%)
46% less call options, than puts
Call options by funds: $136M | Put options by funds: $252M
Holders
181
Holding in Top 10
12
Calls
$136M
Puts
$252M
Top Buyers
| 1 | +$95.8M | |
| 2 | +$69.8M | |
| 3 | +$49.6M | |
| 4 |
FAM
Fred Alger Management
New York
|
+$44.8M |
| 5 |
AC
Armistice Capital
New York
|
+$39.8M |
Top Sellers
| 1 | -$101M | |
| 2 | -$35M | |
| 3 | -$31.4M | |
| 4 |
Two Sigma Investments
New York
|
-$25.5M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
-$25M |